Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email Alendronate prevents bone loss at the hip Bone mineral density at the hip increased during two years of treatment with aldendronate, while decreasing in those receiving placebo. Women treated with 5 mg of alendronate had greater increases in bone mineral density than those treated with 2.5 mg, and slightly smaller increases than women receiving estrogen and progestin. Data from: Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 1998; 338:485.